CA3136060C - Composes inhibiteurs de l'echangeur sodium-hydrogene 3 - Google Patents

Composes inhibiteurs de l'echangeur sodium-hydrogene 3

Info

Publication number
CA3136060C
CA3136060C CA3136060A CA3136060A CA3136060C CA 3136060 C CA3136060 C CA 3136060C CA 3136060 A CA3136060 A CA 3136060A CA 3136060 A CA3136060 A CA 3136060A CA 3136060 C CA3136060 C CA 3136060C
Authority
CA
Canada
Prior art keywords
compound
pharmaceutically acceptable
acceptable salt
formula
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3136060A
Other languages
English (en)
Other versions
CA3136060A1 (fr
Inventor
Kostas GAVARDINAS
Prabhakar Jadhav
Xiaojun Wang
John Rowley WETTERAU
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Priority claimed from PCT/US2020/031999 external-priority patent/WO2020231770A1/fr
Publication of CA3136060A1 publication Critical patent/CA3136060A1/fr
Application granted granted Critical
Publication of CA3136060C publication Critical patent/CA3136060C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

Il est décrit des composés d'inhibiteur-échangeur sodium-hydrogène 3 (NHE3) de la Formule. Il est également décrit des compositions pharmaceutiques comprenant le composé et l'utilisation du composé dans le traitement de certaines maladies liées à des teneurs élevées en sodium ou en phosphate.
CA3136060A 2019-05-16 2020-05-08 Composes inhibiteurs de l'echangeur sodium-hydrogene 3 Active CA3136060C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962848652P 2019-05-16 2019-05-16
US62/848,652 2019-05-16
PCT/US2020/031999 WO2020231770A1 (fr) 2019-05-16 2020-05-08 Composés inhibiteurs de l'échangeur sodium-hydrogène 3

Publications (2)

Publication Number Publication Date
CA3136060A1 CA3136060A1 (fr) 2020-11-19
CA3136060C true CA3136060C (fr) 2025-11-04

Family

ID=

Similar Documents

Publication Publication Date Title
US20250382271A1 (en) Sodium-hydrogen exchanger 3 inhibitor compounds
WO2016007046A1 (fr) 2-thioxo-imidazolidine-4-ones substitués et leur spiro-analogues, composant actif anticancéreux, composition pharmaceutique, préparation médicamenteuse et procédé de traitement du cancer de la prostate
CA3181902A1 (fr) Mehodes de traitement ou de prevention de maladie renale chronique
EP3984534A1 (fr) Composé de diarylamide et son application
CA3136060C (fr) Composes inhibiteurs de l'echangeur sodium-hydrogene 3
JP2018535226A (ja) ビス−ピリダジン化合物およびがんの治療におけるその使用
EP2729474B1 (fr) Composés de (thiéno[2,3-b][1,5]benzoxazépin-4-yl)pipérazin-1-yle possédant une double activité de type agoniste inverse h1/antagoniste 5-ht2a
HK40064283A (en) Sodium-hydrogen exchanger 3 inhibitor compounds
HK40064283B (en) Sodium-hydrogen exchanger 3 inhibitor compounds
DK2683719T3 (en) SUBSTITUTED [(5H-pyrrolo [2,1-c] [1,4] benzodiazepin-11-yl) -piperazin-1-yl] -2,2-DIMETHYLPROPANSYREFORBINDELSER as double acting H1-inverse agonists / 5-HT 2A antagonists
KR102401144B1 (ko) 우레아 유도체
EA047003B1 (ru) Соединения-ингибиторы натрий-водородного обменника 3
KR20230116005A (ko) Cdc7 억제제로 사용되는 염 형태 및 이의 결정 형태
CN106810532B (zh) 一类胺烷氧基噻吨酮类化合物、其制备方法和用途
CN113825763B (zh) 一种N-(β-L-吡喃鼠李糖基)阿魏酸酰胺的制备方法及应用
WO2024212137A1 (fr) Formes cristallines d'un composé d'acide 1h-1, 2, 3-triazole-4-carboxylique
WO2003082286A1 (fr) Derives de quinoline, preparations de ces derives et compositions pharmaceutiques comprenant ces derives
CN104610190B (zh) 一类含环丙基脒结构的卤代苯基噻唑羧酸酰胺类化合物及用途
CN110229146A (zh) 组蛋白去乙酰化酶抑制剂及其制备方法与用途
CN104672165A (zh) 一类含环丙基脒结构的烷氧苯基噻唑羧酸酰胺类双靶点抑制剂、其制备方法及用途
CN104610187A (zh) 一类含脒结构的烷氧苯基噻唑羧酸酰胺类双靶点抑制剂、其制备方法及用途
CN104628671A (zh) 含苯基脒结构的硝基苯噻唑羧酸酰胺类化合物及用途